Home / BUSINESS / Lupin launches generic Nystatin and Triamcinolone Acetonide Cream

Lupin launches generic Nystatin and Triamcinolone Acetonide Cream

Lupin has launched Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1%, having received an approval from the United States Food and Drug Administration (USFDA) earlier. Nystatin and Triamcinolone Acetonide Cream had annual sales of $54.3 million in the US as per IQVIA MAT September 2018.

The company’s Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1% is the generic equivalent of Taro Pharmaceuticals’ Nystatin and Triamcinolone Acetonide Cream. It is indicated for the treatment of cutaneous candidiasis.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Please share this news